Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 4, 1994 - Issue 2
Submit an article Journal homepage
14
Views
24
CrossRef citations to date
0
Altmetric
Research

Company Profile: Abbott: analysis of patenting 1989–93

Peter Steele Intellectual Property Consultancy, Suite 18, Roman House, 9-10 College Terrace, London, E3 5AN, UK
Pages 99-108 | Published online: 03 Mar 2008

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (24)

Peter R Steele. (1996) Company Profile: Eisai: analysis of patenting 1993-1996. Expert Opinion on Therapeutic Patents 6:11, pages 1131-1138.
Read now
Peter Steele. (1996) Company Profile Sankyo: analysis of patenting 1993 – 1996. Expert Opinion on Therapeutic Patents 6:10, pages 955-965.
Read now
Peter Steele. (1996) Company Profile: Monsanto: Analysis of patenting 1993–1996. Expert Opinion on Therapeutic Patents 6:7, pages 611-617.
Read now
Peter Steele. (1996) Company Profile: Boehringer Ingelheim: Analysis of patenting 1992 - 1995. Expert Opinion on Therapeutic Patents 6:1, pages 1-9.
Read now
Peter Steele. (1995) Company Profile Sanofi: Analysis of patenting 1992–1995. Expert Opinion on Therapeutic Patents 5:12, pages 1259-1267.
Read now
Peter Steele. (1995) Company Profile Part Two Upjohn: Analysis of Patenting 1992-1995. Expert Opinion on Therapeutic Patents 5:11, pages 1155-1161.
Read now
Peter Steele. (1995) Company Profile: Part One Pharmacia: Analysis of Patenting 1992-1995. Expert Opinion on Therapeutic Patents 5:11, pages 1147-1154.
Read now
Peter Steele. (1995) Company Profile: Warner-Lambert: analysis of patenting 1992 – 1995. Expert Opinion on Therapeutic Patents 5:10, pages 1015-1025.
Read now
Peter Steele. (1995) Company Profile Sandoz: Analysis of patenting 1991–1995. Expert Opinion on Therapeutic Patents 5:8, pages 735-745.
Read now
Peter Steele. (1995) Company Profile: Yamanouchi: analysis of patenting 1989-1995. Expert Opinion on Therapeutic Patents 5:7, pages 611-622.
Read now
Peter Steele. (1995) Company Profile: Bristol-Myers Squibb: analysis of patenting 1992–1995. Expert Opinion on Therapeutic Patents 5:6, pages 517-528.
Read now
Peter Steele. (1995) Company Profile Ciba-Geigy: analysis of patenting 1991 - 1995. Expert Opinion on Therapeutic Patents 5:5, pages 381-389.
Read now
Peter Steele. (1995) Company Profile Zeneca: Analysis of patenting 1991–1995. Expert Opinion on Therapeutic Patents 5:4, pages 277-285.
Read now
Peter Steele. (1995) Company Profile: Johnson & Johnson: analysis of patenting 1989–1995. Expert Opinion on Therapeutic Patents 5:3, pages 199-210.
Read now
Peter Steele. (1995) Company Profile: Wellcome: analysis of patenting 1989 – 1995. Expert Opinion on Therapeutic Patents 5:3, pages 191-198.
Read now
Peter Steele. (1995) Company Profile: Pfizer Inc: analysis of patenting 1989-1994. Expert Opinion on Therapeutic Patents 5:2, pages 99-110.
Read now
Peter Steele. (1994) Company Profile: F Hoffmann-La Roche Ltd: Analysis of patenting 1991 - 1994. Expert Opinion on Therapeutic Patents 4:12, pages 1437-1444.
Read now
Peter Steele. (1994) Company Profile: Hoechst: Analysis of patenting 1991–1994. Expert Opinion on Therapeutic Patents 4:11, pages 1309-1318.
Read now
Peter Steele. (1994) Company Profile Merck & Co Inc: Analysis of patenting 1991–1994. Expert Opinion on Therapeutic Patents 4:10, pages 1161-1172.
Read now
Peter Steele. (1994) Company Profile: Schering-Plough: Analysis of patenting 1989–1994. Expert Opinion on Therapeutic Patents 4:8, pages 903-910.
Read now
Peter Steele. (1994) Company Profile: Rhône-Poulenc Rorer: Analysis of patenting 1989–94. Expert Opinion on Therapeutic Patents 4:7, pages 751-760.
Read now
Peter Steele. (1994) Company Profile: Takeda: analysis of patenting 1989–94. Expert Opinion on Therapeutic Patents 4:6, pages 611-619.
Read now
Peter Steele. (1994) Company Profile: Glaxo: analysis of patenting, 1989–93. Expert Opinion on Therapeutic Patents 4:5, pages 479-487.
Read now
Peter Steele. (1994) Company Profile: Smithkline Beecham: analysis of patenting 1989–93. Expert Opinion on Therapeutic Patents 4:4, pages 303-313.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.